Changes in the prevalence of hypothyroidism: The HUNT study in Norway

European Journal of Endocrinology

Volumn 169, Issue 5, 2013, Pages 613-620

  Åsvold, Bjern Olav ^a,b   Vatten, Lars J ^a,c   Bjøro, Trine ^d,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; NORWAY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION TEST;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; NORWAY; PREVALENCE; SEX FACTORS; THYROID FUNCTION TESTS; YOUNG ADULT;

EID: 84885132325     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0459     Document Type: Article

References (27)

1. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131. (doi:10.1210/er.2006- 0043)
2. Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L & Brochmann H. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). European Journal of Endocrinology 2000 143 639-647. (doi:10.1530/eje.0.1430639)
3. Canaris GJ, Manowitz NR, Mayor G & Ridgway EC. The Colorado thyroid disease prevalence study Archives of Internal Medicine 2000 160 526-534. (doi:10.1001/archinte.160.4.526)
4. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA & Braverman LE. Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 2002 87 489-499. (doi:10.1210/jc.87.2.489)
5. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T & Smith PA. The spectrum of thyroid disease in a community: the Whickham survey Clinical Endocrinology 1977 7 481-493. (doi:10.1111/j.1365- 2265.1977. tb01340.x)
6. Vanderpump MP. The epidemiology of thyroid disease. British Medical Bulletin 2011 99 39-51. (doi:10.1093/bmb/ldr030)
7. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality Journal of the American Medical Association 2010 304 1365-1374. (doi:10.1001/jama.2010.1361)
8. Holmen J, Midthjell K, Krüger O, Langhammer A, Holmen TL, Bratberg GH, Vatten LJ & Lund-Larsen PG. The Nord-Trondelag Health Study 1995-97 (HUNT 2): objectives, contents, methods, and participation. Norsk Epidemiologi 2003 13 19-32.
9. Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, Bratberg G, Heggland J & Holmen J. Cohort profile: the HUNT Study Norway International Journal of Epidemiology 2013 42 968-977. (doi:10.1093/ije/dys095)
10. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Volzke H et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Archives of Internal Medicine 2012 172 799-809. (doi:10.1001/archinternmed.2012.402)
11. Wilson S, Parle JV, Roberts LM, Roalfe AK, Hobbs FD, Clark P, Sheppard MC, Gammage MD, Pattison HM & Franklyn JA. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. Journal of Clinical Endocrinology and Metabolism 2006 91 4809-4816. (doi:10.1210/jc.2006-1557)
12. Mitchell AL, Hickey B, Hickey JL & Pearce SH. Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health 2009 9 132. (doi:10.1186/1471-2458-9-132)
13. Leese GP Flynn RV Jung RT, Macdonald TM, Murphy MJ & Morris AD. Increasing prevalence and incidence ofthyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clinical Endocrinology 2008 68 311-316. (doi:10.1111/j.1365-2265.2007.03051.x)
14. Cerqueira C, Knudsen N, Ovesen L, Laurberg P, Perrild H, Rasmussen LB & Jorgensen T. Doubling in the use of thyroid hormone replacement therapy in Denmark: association to iodization of salt? European Journal of Epidemiology 2011 26 629-635. (doi:10.1007/s10654-011-9590-5)
15. Kapelrud H, Frey H & Theodorsen L. Excretion of iodine in the urine. A study from 6 different Norwegian districts in 1985. Tidsskrijt for DenNorskeLaegeforening 1987 107 1320-1321, 1317.
16. Asvold BO, Bjoro T, Nilsen TI & Vatten LJ. Tobacco smoking and thyroid function: a population-based study Archives of Internal Medicine 2007 167 1428-1432. (doi:10.1001/archinte.167.13.1428)
17. Carle A, Bulow Pedersen I, Knudsen N, Perrild H, Ovesen L, Banke Rasmussen L, Jorgensen T & Laurberg P. Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study Clinical Endocrinology 2012 77 764-772. (doi:10.1111/j. 1365-2265.2012.04455.x)
18. Carle A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jorgensen T & Laurberg P. Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population-based case-control study European Journal of Endocrinology 2012 167 483-490. (doi:10.1530/EJE-12-0356)
19. Reinehr T. Obesity and thyroid function. Molecular and Cellular Endocrinology 2010 316 165-171. (doi:10.1016/j.mce.2009. 06.005)
20. Rotondi M, Leporati P, La Manna A, Pirali B, Mondello T, Fonte R, Magri F & Chiovato L. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? European Journal of Endocrinology 2009 160 403-408. (doi:10.1530/EJE-08-0734)
21. Svare A, Nilsen TI, Bjoro T, Asvold BO & Langhammer A. Serum TSH related to measures of body mass: longitudinal data from the HUNT Study Norway Clinical Endocrinology 2011 74 769-775. (doi:10.1111/j.1365-2265.2011.04009.x)
22. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 2004 291 228-238. (doi:10.1001/jama.291.2.228)
23. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA & McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Journal of Clinical Endocrinology and Metabolism 2005 90 581-585 discussion 586-587. (doi: 10.1210/jc.2004-1231)
24. Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U. S. Preventive Services Task Force. Annals of Internal Medicine 2004 140 128-141. (doi:10.7326/0003-4819-140-2- 200401200-00015)
25. Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O'Leary PC & Walsh JP. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. Journal of Clinical Endocrinology and Metabolism 2012 97 1554-1562. (doi:10.1210/jc.2011-3020)
26. Surks MI & Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 4575-4582. (doi:10.1210/jc.2007-1499)
27. Fatourechi V, Lankarani M, Schryver PG, Vanness DJ, Long KH & Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/l). Mayo Clinic Proceedings. Mayo Clinic 2003 78 554-560. (doi:10.4065/78.5.554)